GuidanceMHRA
Clinical trials for medicines: Notification of Serious Breaches of GCP or the trial protocol
Information on practical arrangements for notification, what should and should not be classified as a “serious breach” and what must be reported.
First published: Apr 27, 2026Last updated: Apr 27, 2026Changes: 1
Latest change: First published.
The full document, source attachments, and change history are available on KeyPedia. Sign in to view.